Therapeutic advances in the management of lupus nephritis: ¿What's new in translational medicine?

Authors

DOI:

https://doi.org/10.58597/rpe.v4i2.114

Keywords:

Lupus Nephritis, Lupus Erythematosus, Belimumab, Voclosporin

Abstract

N/A

Downloads

Download data is not yet available.

References

Peyronel F, Rossi GM, Palazzini G, Odone L, Errichiello C, Emmi G, et al. Early-onset lupus nephritis. Clin Kidney J [Internet]. 2024;17(8):1–2. Available from: doi:10.1093/ckj/sfae212

Yu XX, Deng J, Chen QX, Qiu SY, Jiang CH, Wu YQ, et al. Long-term outcomes and predictive factors of achieving low disease activity status in childhood systemic lupus erythematosus: a Chinese bicentric retrospective registered study. Front Immunol [Internet]. 2024;15:1–2. Available from: doi:10.3389/fimmu.2024.1369969

Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R. Comparison of lupus nephritis induction treatments in a hispanic population: A single-center cohort analysis. J Rheumatol [Internet]. 2015;42(11):2082–91. Available from: doi:10.3899/jrheum.150395

Lin Z, Jiang B, Wang W, Chen C, Wang Y, Wan J, et al. Clinical outcomes in lupus nephritis patients treated with belimumab in real-life setting: a retrospective comparative study in China. PeerJ [Internet]. 2024;12(9):1–2. Available from: doi:10.7717/peerj.18028

Li H, Chen C, Yang H, Tu J. Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritis. Eur J Pediatr [Internet]. 2024;183(9):3987–95. Available from: doi:10.1007/s00431-024-05662-9

Menn-Josephy H, Hodge LS, Birardi V, Leher H. Efficacy of Voclosporin in Proliferative Lupus Nephritis with High Levels of Proteinuria. Clin J Am Soc Nephrol [Internet]. 2024;19(3):309–18. Available from: doi:10.2215/CJN.0000000000000297

Rovin BH, Teng YKO, Ginzler EM, Arriens C, Caster DJ, Romero-Diaz J, et al. Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet [Internet]. 2021;397(10289):2070–80. Available from: doi:10.1016/S0140-6736(21)00578-X

Published

2025-06-30

Issue

Section

Carta al editor

How to Cite

1.
Serna-Trejos JS, Bermúdez-Moyano SG, Perea-Serna MC. Therapeutic advances in the management of lupus nephritis: ¿What’s new in translational medicine?. Rev Pediatr Espec [Internet]. 2025 Jun. 30 [cited 2026 Jun. 5];4(2):88-90. Available from: https://revistapediatricae.insn.gob.pe/index.php/rpe/article/view/114